Overview

Effect of Inflammation on Pharmacokinetics of Posaconazole

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Posaconazole plasma concentration and inflammatory markers will be determined in all samples available from routine analysis.
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Posaconazole